tirzepatide approved for osa Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says Obstructive sleep apnea with obesity:

It is often triggered by stress, illness, or medication changes

In the future, this therapy may be an effective option for adults who are struggling with obesity or excess weight, especially if previous attempts with diet and exercise alone have not led to lasting results

The medications impact on blood sugar control and reduction of cardiovascular risk factors supports a healthier lifestyle long-term

According to a 2024 review in Nature Reviews Drug Discovery , the next generation of anti-obesity medications will likely combine multiple hormonal pathways to achieve weight loss results that approach those of bariatric surgery, but without the surgical risks

Tirzepatide weight loss data The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight (BMI 27 or higher with at least one weight-related comorbidity) without type 2 diabetes